BRPI0520012A2 - identificação de marcadores moleculares de diagnóstico para endometriose em linfócitos do sangue - Google Patents
identificação de marcadores moleculares de diagnóstico para endometriose em linfócitos do sangueInfo
- Publication number
- BRPI0520012A2 BRPI0520012A2 BRPI0520012-1A BRPI0520012A BRPI0520012A2 BR PI0520012 A2 BRPI0520012 A2 BR PI0520012A2 BR PI0520012 A BRPI0520012 A BR PI0520012A BR PI0520012 A2 BRPI0520012 A2 BR PI0520012A2
- Authority
- BR
- Brazil
- Prior art keywords
- endometriosis
- identification
- value
- blood lymphocyte
- molecular markers
- Prior art date
Links
- 201000009273 Endometriosis Diseases 0.000 title abstract 3
- 210000004698 lymphocyte Anatomy 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 210000000265 leukocyte Anatomy 0.000 abstract 3
- 210000005259 peripheral blood Anatomy 0.000 abstract 3
- 239000011886 peripheral blood Substances 0.000 abstract 3
- 230000014509 gene expression Effects 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65433105P | 2005-02-18 | 2005-02-18 | |
| PCT/US2005/044723 WO2006091254A1 (en) | 2005-02-18 | 2005-12-09 | Identification of molecular diagnostic markers for endometriosis in blood lymphocytes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0520012A2 true BRPI0520012A2 (pt) | 2009-04-14 |
Family
ID=36182367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0520012-1A BRPI0520012A2 (pt) | 2005-02-18 | 2005-12-09 | identificação de marcadores moleculares de diagnóstico para endometriose em linfócitos do sangue |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090208939A1 (https=) |
| EP (1) | EP1848818A1 (https=) |
| JP (1) | JP2008537474A (https=) |
| KR (1) | KR20080016789A (https=) |
| CN (1) | CN101124340A (https=) |
| AU (1) | AU2005327929A1 (https=) |
| BR (1) | BRPI0520012A2 (https=) |
| CA (1) | CA2596932A1 (https=) |
| IL (1) | IL184920A0 (https=) |
| MX (1) | MX2007009562A (https=) |
| NO (1) | NO20074762L (https=) |
| WO (1) | WO2006091254A1 (https=) |
| ZA (1) | ZA200707752B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9222938B2 (en) * | 2001-12-04 | 2015-12-29 | Michael Tainsky | Neoepitope detection of disease using protein arrays |
| EP2118321A4 (en) * | 2007-02-06 | 2010-06-30 | Genizon Biosciences | GENCARTS OF HUMAN GENES ASSOCIATED WITH ENDOMETRIOSIS |
| US11287425B2 (en) | 2009-04-22 | 2022-03-29 | Juneau Biosciences, Llc | Genetic markers associated with endometriosis and use thereof |
| US8932993B1 (en) | 2007-06-11 | 2015-01-13 | Juneau Biosciences, LLC. | Method of testing for endometriosis and treatment therefor |
| WO2009140126A1 (en) * | 2008-05-14 | 2009-11-19 | Juneau Biosciences, Llc | Method of administering a therapeutic |
| JP5503942B2 (ja) | 2009-10-30 | 2014-05-28 | シスメックス株式会社 | 疾患の罹患の判定方法 |
| EP2348129A1 (en) * | 2010-01-21 | 2011-07-27 | Sanofi | Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| KR101333207B1 (ko) * | 2011-07-13 | 2013-11-26 | 부산대학교 산학협력단 | 자궁내막증과 연관된 유전자 마커 및 이의 용도 |
| WO2013067451A2 (en) | 2011-11-04 | 2013-05-10 | Population Diagnostics Inc. | Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
| US10407724B2 (en) | 2012-02-09 | 2019-09-10 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
| KR101445560B1 (ko) * | 2012-05-10 | 2014-09-29 | 한국수력원자력 주식회사 | 저준위 전리방사선에 민감한 유전자 검출 방법 및 상기 방법으로 검출된 유전자 |
| EP2895621B1 (en) | 2012-09-14 | 2020-10-21 | Population Bio, Inc. | Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
| US9434991B2 (en) | 2013-03-07 | 2016-09-06 | Juneau Biosciences, LLC. | Method of testing for endometriosis and treatment therefor |
| US20160244834A1 (en) * | 2013-06-28 | 2016-08-25 | Acumen Research Laboratories Pte. Ltd. | Sepsis biomarkers and uses thereof |
| DK2891722T3 (en) | 2013-11-12 | 2019-01-07 | Population Bio Inc | METHODS AND COMPOSITIONS FOR DIAGNOSTICING, PROGRAMMING AND TREATMENT OF ENDOMETRIOSIS |
| DE102014203235A1 (de) * | 2014-02-24 | 2015-08-27 | Mahle International Gmbh | Klimagerät, insbesondere für ein Kraftfahrzeug und Verfahren zur Herstellung einer Komponente eines Klimagerätes |
| RU2558854C1 (ru) * | 2014-06-23 | 2015-08-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Способ прогнозирования риска развития эндометриоза |
| JP2016077234A (ja) * | 2014-10-17 | 2016-05-16 | 国立大学法人鳥取大学 | 子宮内膜症の早期診断のための診断キット、診断マーカー及び検出方法 |
| CN107326065B (zh) * | 2016-04-29 | 2022-07-29 | 博尔诚（北京）科技有限公司 | 一种基因标识物的筛选方法及其应用 |
| CN107858415B (zh) * | 2016-09-19 | 2021-05-28 | 深圳华大生命科学研究院 | 用于子宫腺肌症检测的生物标志物组合及其应用 |
| US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
| US10729693B2 (en) * | 2018-03-02 | 2020-08-04 | Ponce Medical School Foundation, Inc. | Compositions and methods for the treatment of endometriosis |
| CN108456723A (zh) * | 2018-03-21 | 2018-08-28 | 福州福瑞医学检验实验室有限公司 | 一种子宫内膜异位症风险预测的基因检测引物和试剂盒 |
| CN112470002A (zh) * | 2018-04-20 | 2021-03-09 | 德克萨斯大学体系董事会 | 用于治疗子宫内膜异位症的组合物和方法 |
| US11906529B1 (en) * | 2018-04-27 | 2024-02-20 | Marshall University Research Corporation | Methods for treatment and diagnosis of endometriosis |
| DE24173683T1 (de) | 2018-08-08 | 2024-11-07 | Pml Screening, Llc | Verfahren zur beurteilung des risikos der entwicklung einer viruserkrankung unter verwendung eines genetischen tests |
| EP4732304A2 (en) * | 2023-06-21 | 2026-04-29 | Cristcot LLC | Development and validation of the hemorrhoid disease symptom impact measure |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003253440A1 (en) * | 2002-08-30 | 2004-04-30 | Japan As Represented By The President Of The University Of Tokyo | Method of diagnosing ovarian endometriosis |
-
2005
- 2005-12-09 JP JP2007556134A patent/JP2008537474A/ja not_active Withdrawn
- 2005-12-09 WO PCT/US2005/044723 patent/WO2006091254A1/en not_active Ceased
- 2005-12-09 MX MX2007009562A patent/MX2007009562A/es not_active Application Discontinuation
- 2005-12-09 US US11/884,402 patent/US20090208939A1/en not_active Abandoned
- 2005-12-09 EP EP05853605A patent/EP1848818A1/en not_active Withdrawn
- 2005-12-09 CA CA002596932A patent/CA2596932A1/en not_active Abandoned
- 2005-12-09 KR KR1020077021464A patent/KR20080016789A/ko not_active Withdrawn
- 2005-12-09 CN CNA2005800484494A patent/CN101124340A/zh active Pending
- 2005-12-09 AU AU2005327929A patent/AU2005327929A1/en not_active Abandoned
- 2005-12-09 BR BRPI0520012-1A patent/BRPI0520012A2/pt not_active Application Discontinuation
-
2007
- 2007-07-30 IL IL184920A patent/IL184920A0/en unknown
- 2007-09-11 ZA ZA200707752A patent/ZA200707752B/xx unknown
- 2007-09-18 NO NO20074762A patent/NO20074762L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101124340A (zh) | 2008-02-13 |
| JP2008537474A (ja) | 2008-09-18 |
| WO2006091254A1 (en) | 2006-08-31 |
| ZA200707752B (en) | 2010-05-26 |
| EP1848818A1 (en) | 2007-10-31 |
| MX2007009562A (es) | 2008-03-11 |
| IL184920A0 (en) | 2007-12-03 |
| KR20080016789A (ko) | 2008-02-22 |
| AU2005327929A1 (en) | 2006-08-31 |
| US20090208939A1 (en) | 2009-08-20 |
| CA2596932A1 (en) | 2006-08-31 |
| NO20074762L (no) | 2007-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0520012A2 (pt) | identificação de marcadores moleculares de diagnóstico para endometriose em linfócitos do sangue | |
| Bonanzinga et al. | The role of alpha defensin in prosthetic joint infection (PJI) diagnosis: a literature review | |
| Davenport et al. | Functional definition and characterization of acute traumatic coagulopathy | |
| Ryu et al. | Bioactive plasma mitochondrial DNA is associated with disease progression in scleroderma‐associated interstitial lung disease | |
| Bozza et al. | Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? | |
| Hristozova et al. | A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers | |
| WO2006125973A3 (en) | Diagnosis of tuberculosis using gene expression marker analysis | |
| George et al. | Profiling of kidney injury biomarkers in patients receiving cisplatin: time‐dependent changes in the absence of clinical nephrotoxicity | |
| Greene et al. | Facilitating the laboratory diagnosis of α1-antitrypsin deficiency | |
| WO2008041953A3 (en) | Dengue diagnosis and treatment | |
| BR112015015400A2 (pt) | métodos e sistemas de enumeração de plaquetas imaturas | |
| US20110217719A1 (en) | Methods and kits for diagnosing obstructive sleep apnea | |
| Warang et al. | Flow cytometric osmotic fragility—an effective screening approach for red cell membranopathies | |
| Gomes et al. | Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia | |
| BR112014011563A2 (pt) | métodos para detectar o papiloma-vírus humano e fornecer o prognóstico para carci-noma de células escamosas de cabeça e pescoço | |
| Chen et al. | Elevated plasma and vitreous levels of leucine‐rich‐α2‐glycoprotein are associated with diabetic retinopathy progression | |
| ES2549860T3 (es) | Diagnóstico y pronóstico de estados patológicos relacionados con la dipepitidil peptidasa | |
| US20160091513A1 (en) | Test strips for determining coagulation factor activities | |
| Nelles et al. | Platelet mapping assay interference due to platelet activation in heparinized samples | |
| Shteinshnaider et al. | Prognostic significance of changes in red cell distribution width in an internal medicine ward | |
| US9045792B2 (en) | In vitro method for analyzing a comparison of an indicative numberic value to a predetermined threshold so as to assess a likelihood of risk or presence of organ failure | |
| Sampson et al. | Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes | |
| Anupama et al. | Correlation between serum ferritin and bone marrow iron stores | |
| Hegen et al. | Cerebrospinal fluid: serum glucose ratio in the ventricular and lumbar compartments: implications for clinical practice | |
| Katsoulos et al. | Evaluation of a portable glucose meter for use in cattle and sheep |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |